Iron increases the susceptibility of colorectal cancer cells to compound Kushen Injection via the decrease of TOP2A and p53
Background: Colorectal cancer (CRC) is one type of worldwide refractory tumors with high morbidity and mortality. Iron is responsible for the development and progression of CRC. Whereas, iron-deficiency anemia is a common comorbidity and a major cause of tumor aggressiveness in CRC patients. Thus, t...
Saved in:
Main Authors: | Xingkang Wu (Author), Chenchen Han (Author), Lu Wang (Author), Xuemei Qin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer
by: Yi Li, et al.
Published: (2021) -
Compound Kushen Injection Protects Skin From Radiation Injury via Regulating Bim
by: Jianxiao Zheng, et al.
Published: (2021) -
Compound kushen injection in cancer treatments: Efficacy, active ingredients, and mechanisms
by: Yang Yang, et al.
Published: (2022) -
Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology
by: Wei Zhou, et al.
Published: (2020) -
Compound Kushen Injection Induces Immediate Hypersensitivity Reaction Through Promoting the Production of Platelet-Activating Factor via de Novo Pathway
by: Yuan Gao, et al.
Published: (2021)